Breast cancers T1a,b N0 M0 (RPC 2013)

被引：3
作者：
Lacroix-Triki, M.
Jacot, W.
Belkacemi, Y.
Dalenc, F.
Cottu, P.
Rodrigues, M.
Coeffic, D.
机构：
[1] Oncologie Médicale, Institut Curie, Paris
[2] Pathologiste Toulouse, Toulouse
[3] Oncologie Médicale, Montpellier
[4] Radiothérapie, Créteil
[5] Oncologie Médicale, Toulouse
[6] Oncologie Médicale, Paris
[7] Oncologie Médicale, Neuilly-sur-Seine
来源：
ONCOLOGIE | 2013年 / 15卷 / 12期
关键词：
RANDOMIZED CLINICAL-TRIAL; ADJUVANT ENDOCRINE THERAPY; LUMPECTOMY PLUS TAMOXIFEN; STAGE-I T1N0M0; WHOLE-BREAST; RADIATION-THERAPY; GENE-EXPRESSION; CONSERVING SURGERY; PROGNOSTIC-FACTORS; TUMOR SIZE;
D O I：
10.1007/s10269-013-2344-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：637 / 672
页数：36
相关论文
共 176 条
  • [1] Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Aebi, S.
    Davidson, T.
    Gruber, G.
    Cardoso, F.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : vi12 - vi24
  • [2] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
    Albain, K.
    Anderson, S.
    Arriagada, R.
    Barlow, W.
    Bergh, J.
    Bliss, J.
    Buyse, M.
    Cameron, D.
    Carrasco, E.
    Clarke, M.
    Correa, C.
    Coates, A.
    Collins, R.
    Costantino, J.
    Cutter, D.
    Cuzick, J.
    Darby, S.
    Davidson, N.
    Davies, C.
    Davies, K.
    Delmestri, A.
    Di Leo, A.
    Dowsett, M.
    Elphinstone, P.
    Evans, V.
    Ewertz, M.
    Gelber, R.
    Gettins, L.
    Geyer, C.
    Goldhirsch, A.
    Godwin, J.
    Gray, R.
    Gregory, C.
    Hayes, D.
    Hill, C.
    Ingle, J.
    Jakesz, R.
    James, S.
    Kaufmann, M.
    Kerr, A.
    MacKinnon, E.
    McGale, P.
    McHugh, T.
    Norton, L.
    Ohashi, Y.
    Paik, S.
    Pan, H. C.
    Perez, E.
    Peto, R.
    Piccart, M.
    [J]. LANCET, 2012, 379 (9814) : 432 - 444
  • [3] Amir E, 2011, CANC RES S, V71
  • [4] Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis
    Amir, Eitan
    Seruga, Bostjan
    Niraula, Saroj
    Carlsson, Lindsay
    Ocana, Alberto
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (17): : 1299 - 1309
  • [5] Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer
    Anderson, William F.
    Chen, Bingshu E.
    Jatoi, Ismail
    Rosenberg, Philip S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (01) : 121 - 126
  • [6] [Anonymous], 2011, MIS JOUR 2011 COMPT
  • [7] Ash D V, 1995, Clin Oncol (R Coll Radiol), V7, P93, DOI 10.1016/S0936-6555(05)80808-8
  • [8] Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers
    Baak, J. P. A.
    van Diest, P. J.
    Janssen, E. A. M.
    Gudlaugsson, E.
    Voorhorst, F. J.
    van der Wall, E.
    Vermorken, J. B.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (04) : 649 - 654
  • [9] Factors associated with surgical and radiation therapy for early stage breast cancer in older women
    BallardBarbash, R
    Potosky, AL
    Harlan, LC
    Nayfield, SG
    Kessler, LG
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (11): : 716 - 726
  • [10] Management of small HER2-positive breast cancers
    Banerjee, Susana
    Smith, Ian E.
    [J]. LANCET ONCOLOGY, 2010, 11 (12) : 1193 - 1199
12345678910